SHARING GAINS AND RISKS: THE NEXT FRONTIER IN ATMPS
Tracks
RAMÓN MARGALEF ROOM
| Wednesday, October 8, 2025 |
| 15:15 - 16:00 |
| RAMÓN MARGALEF ROOM |
Overview
Sponsor: Biocat
Details
This roundtable will address the main challenges in the adoption and reimbursement of advanced therapies within public healthcare systems, with a focus on regulatory complexity, budgetary constraints, and the uncertainties surrounding clinical and economic evidence. It will explore the risks to be assumed by key stakeholders — including HTA bodies, policymakers, clinicians, regulators, and industry — as well as innovative reimbursement models such as risk-sharing agreements and outcome-based payments, and public-private collaboration strategies aimed at ensuring equity and system sustainability.
Details
Biocat .
.BIOCAT
Sponsor
Mr Robert Fabregat
CEO
BIOCAT
Moderator
Mr Pablo Méndez
Head of Market Access & Public Affairs, Iberia
CLS BHERING
Speaker
Dr Stefanos Theoharis
CEO
Onechain Immunotherapeutics
Speaker
Dr David Morrow
Scientific Lead for Advanced Therapies
EATRIS
Speaker
Dr Sandra García Armesto
Director
AQUAS
Speaker
Ms Lidia Cánovas Méndez
Key Accounts Director
Asphalion
Speaker
